ReviewHealthcare (Basel, Switzerland)2026
Healthcare Information Management and Accreditation in Europe.
Review in Healthcare (Basel, Switzerland), 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
7 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
BACKGROUND/
objectivesHealthcare systems increasingly rely on standardized diagnostic information to support clinical decision-making, reimbursement, and public health governance. Although accreditation of medical laboratories underpins trust in diagnostic services, in practice, it is encountered primarily through the way in which accredited status is communicated in routine healthcare documentation. This study examines national rules that govern the communication of accreditation-related information and their relevance for healthcare management and policy.
methodsA descriptive, document-based comparative analysis was conducted across all 42 national accreditation bodies participating in the European Co-operation for Accreditation Multilateral Agreement (EA-MLA). Official regulations and policies governing the use of accreditation symbols and references in medical laboratory documentation were analyzed. Only documents confirmed as valid and in force as of January 2026 were included. The analysis focused on report-level identification, differentiation of accredited and non-accredited results, use beyond reports, and consequences of misuse.
resultsAcross countries, accreditation communication rules define how laboratory results are recognized, reimbursed, and operationally used within healthcare systems. While regulatory detail varies, common requirements exist regarding clear identification of accredited results and safeguards against misinterpretation, which directly influence administrative processes and financing mechanisms. For example, in some healthcare systems, accredited reporting determines eligibility for public reimbursement, while in others, it constitutes a legal prerequisite for providing laboratory services.
conclusionsAccreditation-related communication functions as an element of healthcare information governance rather than a purely technical marker. National variations reflect healthcare policy and management priorities, with implications for efficiency, transparency, and access to care.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.